Form 8-K REVIVA PHARMACEUTICALS For: May 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Reviva Pharmaceuticals (RVPH) Enters $50M ATM Offering
May 30, 2025 4:13 PM EDTOn May 30, 2025, Reviva Pharmaceuticals (NASDAQ: RVPH) entered into an At Market Issuance Sales Agreement (the Agreement) with B. Riley Securities, Inc. and Alliance Global Partners, serving as agents (the Agents), with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the Common Stock), having an aggregate offering price of up to $50 million (the Shares) through the Agents (the Offering). Any Shares offered and sold in the Offering will be issued pursuant to... More
